Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Brazil is considering nationwide production of vaccines against the influenza H1N1 virus, the country’s health minister Alexandre Padilha said.
Subscribe to our email newsletter
Padilha was quoted by Xinhua news agency as saying that the country has the technology which can help patients with easy and quick access to the drug when required.
"We only managed to broaden the flu vaccination range because 90 percent of vaccines are already produced in Brazil," Padilha added.
The country has also revealed collaborations with 27 public and private labs to manufacture biopharmaceuticals such as allergy vaccine, a growth hormone, a cicatrizing drug, and medications to treat cancer, arthritis and diabetes, as reported by the news agency.
With these partnerships, Brazil is expecting to manufacture 25 biopharmaceutical drugs in total.
In 2009, the H1N1 virus emerged and resulted in the deaths of 20,000 people across the world. A few cases have been reported again in 2013.